Rare diseases
Investigational molecules
Locations
Back to Spain98 clinical trials in Leon, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
SpainStudy of Atezolizumab, Trastuzumab, and Vinorelbine for Patients with Advanced HER2-Positive Breast Cancer
SpainStudy Comparing Ribociclib and Palbociclib for Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
SpainStudy on Chemotherapy-Free Treatment with Trastuzumab, Pertuzumab, and T-DM1 for Patients with HER2-Positive Early-Stage Breast Cancer
SpainStudy of Chemotherapy with Osimertinib in Non-Small Cell Lung Cancer Patients Who Have Progressed After Initial Osimertinib Treatment
SpainStudy of Ribociclib and Letrozole for Patients with High-Risk Estrogen Receptor-Positive, HER2-Negative Breast Cancer
SpainStudy on Iberdomide and Dexamethasone, Alone or with Drug Combination, for Newly Diagnosed Multiple Myeloma Patients Not Eligible for Transplant
SpainLong-term Study on Treatment Response in Chronic Hepatitis B Patients Using Bepirovirsen
SpainStudy of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy
SpainStudy on Metformin to Prevent High Blood Sugar in Advanced Breast Cancer Patients with Alpelisib and Endocrine Therapy
SpainStudy on Methotrexate and Adalimumab for Non-Infectious Uveitis in Patients: Evaluating Effectiveness and Safety
SpainStudy on Trastuzumab Deruxtecan, Trastuzumab, and Pertuzumab for Patients with HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials targeting various types of cancer, including leukemia, lung cancer, and multiple myeloma. Studies focus on innovative therapeutic approaches combining immunotherapy with conventional treatments.
Research includes evaluation of targeted therapies and novel drug combinations to improve patient outcomes.
Comprehensive research investigating treatments for various heart conditions, with emphasis on coronary artery disease and prevention of cardiovascular events.
Studies aim to improve treatment strategies and reduce cardiovascular complications.
Clinical research addressing urgent medical conditions and metabolic disorders, including septic shock and obesity management.
Focus on developing effective therapeutic approaches for critical conditions and metabolic disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
